Fundamental dimension Equity attribute | CHRLeader $1.310.00% Cap $39.00MP/E 0.0x QuantScore67/100 | ADVPeer $30.28▼-0.20% Cap $402.6MP/E -1.4x QuantScore38/100 | BZFDPeer $0.9643▼-0.59% Cap $84.47MP/E -0.6x QuantScore22/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
28/100 |
82/100 |
35/100 |
Valuation Multiples, PEG & DCF upside | 100/100 | 37/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 75/100 | 22/100 | 16/100 |
Growth Revenue / earnings growth & margins | 32/100 | 16/100 | 9/100 |
Sentiment Analyst ratings, targets & revisions | 100/100 | 33/100 | 16/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 0.0x | -1.4x | -0.6x |
Forward P/E (next FY) | 0.0x | -4.7x | -2.4x |
EV / EBITDA (TTM) | -3.9x | 25.3x | -2.8x |
Price / Sales | 0.3x | 0.1x | 0.5x |
Price / Free Cash Flow | 2.3x | 5.8x | -4.2x |
PEG ratio | -0.00 | -0.41 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 5 / 9 | 3 / 9 |
Altman Z-Score | 3.12 (Safe) | -0.12 (Distress) | -6.15 (Distress) |
Total debt / equity | 0.01 | 3.84 | 0.99 |
Quick ratio | 12.5x | 1.8x | 1.0x |
Interest coverage | — | 0.5x | -4.1x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +1.1% | -0.7% | -2.4% |
Net income growth YoY | -1.3% | +30.3% | -471.8% |
Gross margin (TTM) | 73.6% | 9.1% | 39.2% |
Operating margin (FY) | 17.7% | 0.5% | -7.1% |
FCF margin (FY) | 11.6% | 1.6% | -11.2% |
5. Trailing price performancePrice change over period |
1M return | -18.1% | -10.8% | -6.4% |
3M return | -33.5% | -16.9% | -13.1% |
6M return | -21.6% | -9.3% | +29.6% |
Year to date | -65.9% | +37.6% | +3.7% |
1Y return | -92.9% | -19.3% | -44.6% |
3Y return | -99.8% | -49.5% | -16.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $1,064.78 +81180.5% upside | $1.92 -93.6% premium | $-4.11 -526.5% premium |
Wall Street consensus target | — — | $34.00 +12.3% · range $34.00–$34.00 | $1.00 +3.7% · range $1.00–$1.00 |
Consensus stance | 100% Buy0% Hold0% Sell | 33% Buy67% Hold0% Sell | 33% Buy33% Hold33% Sell |